Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique.

PloS one - 1 Jan 2013

Bila Dulce Celina Adolfo, Young Peter, Merks Harriet, Vubil Adolfo Salvador, Mahomed Mussagy, Augusto Angelo, Abreu Celina Monteiro, Mabunda Nédio Jonas, Brooks James I, Tanuri Amilcar, Jani Ilesh Vinodrai

Abstract excerpt

OBJECTIVE: In Mozambique, highly active antiretroviral treatment (HAART) was introduced in 2004 followed by decentralization and expansion, resulting in a more than 20-fold increase in coverage by 2009. Implementation of HIV drug resistance threshold surveys (HIVDR-TS) is crucial in order to moni...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Mozambique

Share to Pregnancy

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 23935858
DOI: 10.1371/journal.pone.0068213
PMCID: PMC3728366

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23935858-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique.PMID 23935858Read ↗

Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.Semantic proximity Read ↗

Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique.Semantic proximity Read ↗

HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in Mozambique.Semantic proximity Read ↗

HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique.Semantic proximity Read ↗

HIV Dolutegravir Resistance and Multiclass Failure in Mozambique: Findings from a Real-World CohortSemantic proximity Read ↗

HIV-1 Pretreatment and Acquired Antiretroviral Drug Resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique Running title: Pretreatment and Acquired HIV Drug Resistance in MozambiqueSemantic proximity Read ↗

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.Semantic proximity Read ↗

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.Semantic proximity Read ↗

Determinants of virological failure and antiretroviral drug resistance in Mozambique.Semantic proximity Read ↗

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 isolates circulating in pregnant women from Mozambique.Semantic proximity Read ↗

Virological Outcomes and Dolutegravir Resistance Mutations in HIV-infected Patients: A Multicenter Retrospective Cohort Study in MozambiqueSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.